Clinical Trials · NCT01060488
Comparative Validation of the Growth Hormone Releasing Hormone and Arginine Test for the Diagnosis of Adult Growth Hormone Deficiency
- Phase
- Phase 3
- Recruitment status
- Completed
- Sponsor
- Merck KGaA, Darmstadt, Germany
- Enrollment
- 69
- Start date
- Jan 2004
- Locations
- 1 site, France
- Primary endpoint
- Level of GH peak (recorded following stimulation tests)